AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
150 hedge funds and large institutions have $1.97B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 32 increasing their positions, 55 reducing their positions, and 38 closing their positions.
245% more call options, than puts
Call options by funds: $124M | Put options by funds: $35.8M
56% more capital invested
Capital invested by funds: $1.27B → $1.97B (+$705M)
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
3% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 38
1% less funds holding
Funds holding: 152 → 150 (-2)
42% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$59.3M |
| 2 |
Barclays
London,
United Kingdom
|
+$40.4M |
| 3 |
JCI
Jet Capital Investors
New York
|
+$39.4M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$31.7M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
+$21.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
-$37.9M |
| 2 |
AG
Artal Group
Luxembourg
|
-$21.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$19.9M |
| 4 |
Neuberger Berman Group
New York
|
-$13.7M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$12.4M |
AUXL Hedge Fund Activity: Q3 2014 in Review
150 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q3 2014, worth a combined $1.97B — up 56% from $1.27B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of AUXL and 37 opened new positions — a net loss of 1 holder — while 55 trimmed existing stakes and 32 added.
The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $59.3M. The largest seller was TAMRO Capital Partners, exiting entirely with an estimated $37.9M sold.
- 150 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q3 2014, down from 152 in Q2 2014.
- Funds reported $1.97B of AUXILIUM PHARAMCEUTICALS INC stock for Q3 2014, up 56% quarter-over-quarter.
- 37 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q3 2014 and 38 closed out, a net change of -1 holder.
- The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q3 2014 was TIG Advisors LLC, an estimated $59.3M added.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q3 2014 was TAMRO Capital Partners, an estimated $37.9M sold.
Based on aggregated 13F filings for Q3 2014.